Literature DB >> 15298357

The Gly1057Asp polymorphism in IRS-2 interacts with obesity to affect beta cell function.

N Stefan, A Fritsche, F Machicao, O Tschritter, H U Häring, M Stumvoll, M Stumvogel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15298357     DOI： 10.1007/s00125-003-1302-6

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  8 in total

1.  Metabolic characteristics of individuals with impaired fasting glucose and/or impaired glucose tolerance.

Authors:  C Weyer; C Bogardus; R E Pratley
Journal:  Diabetes       Date:  1999-11       Impact factor: 9.461

2.  Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study.

Authors:  M Tominaga; H Eguchi; H Manaka; K Igarashi; T Kato; A Sekikawa
Journal:  Diabetes Care       Date:  1999-06       Impact factor: 19.112

3.  The significance of impaired fasting glucose versus impaired glucose tolerance: importance of insulin secretion and resistance.

Authors:  Gian Piero Carnevale Schianca; Antonello Rossi; Pier Paolo Sainaghi; Elisabetta Maduli; Ettore Bartoli
Journal:  Diabetes Care       Date:  2003-05       Impact factor: 19.112

4.  Insulin secretion and insulin sensitivity in relation to glucose tolerance: lessons from the Botnia Study.

Authors:  D Tripathy; M Carlsson; P Almgren; B Isomaa; M R Taskinen; T Tuomi; L C Groop
Journal:  Diabetes       Date:  2000-06       Impact factor: 9.461

5.  Insulin secretion and insulin sensitivity pattern is different in isolated impaired glucose tolerance and impaired fasting glucose: the risk factor in Impaired Glucose Tolerance for Atherosclerosis and Diabetes study.

Authors:  Markolf Hanefeld; Carsta Koehler; Katja Fuecker; Elena Henkel; Frank Schaper; Theodora Temelkova-Kurktschiev
Journal:  Diabetes Care       Date:  2003-03       Impact factor: 19.112

6.  Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man.

Authors:  D R Matthews; J P Hosker; A S Rudenski; B A Naylor; D F Treacher; R C Turner
Journal:  Diabetologia       Date:  1985-07       Impact factor: 10.122

7.  Insulin resistance is associated with high plasma ouabain-like immunoreactivity concentration in NIDDM.

Authors:  T Wasada; H Kuroki; M Naruse; H Arii; A Maruyama; K Katsumori; S Saito; Y Watanabe; K Naruse; H Demura
Journal:  Diabetologia       Date:  1995-07       Impact factor: 10.122

8.  Insulin resistance as the major cause of impaired glucose tolerance: a self-fulfilling prophesy?

Authors:  S O'Rahilly; A Hattersley; A Vaag; H Gray
Journal:  Lancet       Date:  1994-08-27       Impact factor: 79.321
  8 in total
  3 in total

Review 1.  Effect of genotype on success of lifestyle intervention in subjects at risk for type 2 diabetes.

Authors:  Peter Weyrich; Norbert Stefan; Hans-Ulrich Häring; Markku Laakso; Andreas Fritsche
Journal:  J Mol Med (Berl)       Date:  2006-12-13       Impact factor: 4.599

2.  Dysregulation of insulin receptor substrate 2 in beta cells and brain causes obesity and diabetes.

Authors:  Xueying Lin; Akiko Taguchi; Sunmin Park; Jake A Kushner; Fan Li; Yedan Li; Morris F White
Journal:  J Clin Invest       Date:  2004-10       Impact factor: 14.808

3.  Three Novel Mutations I65S, R66S, and G86R Divulge Significant Conformational Variations in the PTB Domain of the IRS1 Gene.

Authors:  Praveen Chakravarthi Veeraragavulu; Nanda Kumar Yellapu; Sireesha Yerrathota; Pradeepkiran Jangampalli Adi; Bhaskar Matcha
Journal:  ACS Omega       Date:  2019-01-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.